Post-Covid-19 Syndrome: symptoms and stratified follow-up. A systematic review and meta-analysis
https://doi.org/10.4081/wpph.2022.9540
Accepted: 6 July 2022
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Background: Post-COVID-19 syndrome has been found in patients admitted to a hospital with severe conditions of COVID-19 and in adults who initially presented a mild illness. The aim is to underline the available literature on post-COVID-19 follow-up until 12 months about symptoms reported by adults infected with Sars-Cov-2 from at least 12 weeks after disease onset.
Methods: The bibliographic search was conducted on PubMed, Embase, CINHAL, Scopus and the Cochrane Central Register of Controlled Studies.
Results: We found that 68% of patients had at least one symptom post-COVID-19 after 12 weeks and up to 24 weeks post-onset. The most frequent symptoms were fatigue and muscle weakness (26%), dizziness and mental clouding (15%) and taste disturbances (10%).
Conclusions: Health policy needs to prepare for a long-term management plan to address COVID-19, as there are significant needs beyond recovery from the acute infection.
Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20:533–4. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7159018/ DOI: https://doi.org/10.1016/S1473-3099(20)30120-1
Singhal T. A review of coronavirus disease-2019 (COVID-19). Indian J Pediatr. 2020;87:281–6. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090728/ DOI: https://doi.org/10.1007/s12098-020-03263-6
Heneka MT, Golenbock D, Latz E, et al. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimers Res Ther. 2020;12:69. DOI: https://doi.org/10.1186/s13195-020-00640-3
COVID Live Update: 214.081.725 casi e 4.466.769 decessi per coronavirus - Worldometer [Internet]. Available at: https://www.worldometers.info/coronavirus/
Sudre C, Murray B, Varsavsky T, et al. Attributes and predictors of Long-COVID. Nat Med. 2021;27:626-31. DOI: https://doi.org/10.1038/s41591-021-01292-y
Garrigues E, Janvier P, Kherabi Y, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020;81:e4–6. DOI: https://doi.org/10.1016/j.jinf.2020.08.029
Meeting the challenge of long COVID. Nat Med. 2020;26:1803–1803. Available at: http://www.nature.com/articles/s41591-020-01177-6 DOI: https://doi.org/10.1038/s41591-020-01177-6
Overview | COVID-19 rapid guideline: managing the long-term effects of COVID-19 | Guidance | NICE [Internet]. Available at: https://www.nice.org.uk/guidance/ng188
Alpert O, Begun L, Garren P, Solhkhah R. Cytokine storm induced new onset depression in patients with COVID-19. A new look into the association between depression and cytokines -two case reports. Brain Behav Immun - Health. 2020;9:100173. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606074/ DOI: https://doi.org/10.1016/j.bbih.2020.100173
Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet Lond Engl. 2021;397:220–32. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833295/
Carfì A, Bernabei R, Landi F, Gemelli. Against COVID-19 post-acute care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603–5. DOI: https://doi.org/10.1001/jama.2020.12603
Tenforde MW, Kim SS, Lindsell CJ, et al. Symptom duration and risk factors for delayed Return to usual health among outpatients with COVID-19 in a multistate health care systems network — United States, March–June 2020. Morb Mortal Wkly Rep. 2020;69:993–8. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392393/ DOI: https://doi.org/10.15585/mmwr.mm6930e1
Wells G, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomised studies in meta-analyses. [Internet]. 2014. Available at: https://www.semanticscholar.org/paper/The-Newcastle-Ottawa-Scale-(NOS)-for-Assessing-the-Wells-Wells/c293fb316b6176154c3fdbb8340a107d9c8c82bf
Munblit D, Bobkova P, Spiridonova E, et al. Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19. Clin Exp Allergy 2021;51:1107-1120. DOI: https://doi.org/10.1111/cea.13997
Petersen MS, Kristiansen MF, Hanusson KD, et al. Long COVID in the Faroe Islands - a longitudinal study among non-hospitalized patients. Clin Infect Dis Off Publ Infect Dis Soc Am 2020;ciaa1792. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7799340/
The Writing Committee for the COMEBAC Study Group. Four-month clinical status of a cohort of patients after hospitalization for COVID-19. JAMA. 2021;325:1525–34. DOI: https://doi.org/10.1001/jama.2021.3331
Johnsen S, Sattler SM, Miskowiak KW, et al. Descriptive analysis of long COVID sequelae identified in a multidisciplinary clinic serving hospitalised and non-hospitalised patients. ERJ Open Res. 2021;7:00205–2021. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091683/ DOI: https://doi.org/10.1183/23120541.00205-2021
Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet Lond Engl. 2021;397:220–32. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833295/
Blomberg B, Mohn KGI, Brokstad KA, et al. Long COVID in a prospective cohort of home-isolated patients. Nat Med. 2021;1–7. Available at: http://www.nature.com/articles/s41591-021-01433-3
Rao S, Benzouak T, Gunpat S, et al. Fatigue symptoms associated with COVID-19 in convalescent or recovered COVID-19 patients; a systematic review and meta-analysis. Ann Behav Med Publ Soc Behav Med. 2021;kaab081. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8574547/ DOI: https://doi.org/10.31234/osf.io/c4w7p
Doykov I, Hällqvist J, Gilmour KC, et al. ‘The long tail of COVID-19’ - The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients. F1000Research. 2021;9:1349. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745182/ DOI: https://doi.org/10.12688/f1000research.27287.2
Amruta N, Chastain WH, Paz M, et al. SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders. Cytokine Growth Factor Rev. 2021;58:1–15. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894219/ DOI: https://doi.org/10.1016/j.cytogfr.2021.02.002
Chang MC, Park D. Incidence of post-traumatic stress disorder after coronavirus disease. Healthcare. 2020;8:373. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712968/ DOI: https://doi.org/10.3390/healthcare8040373
Mandal S, Barnett J, Brill SE, et al. «Long-COVID»: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76:396–8. DOI: https://doi.org/10.1136/thoraxjnl-2020-215818
Kurian AK, Cardarelli KM. Racial and ethnic differences in cardiovascular disease risk factors: a systematic review. Ethn Dis. 2007;17:143–52.
Pan D, Sze S, Minhas JS, et al. The impact of ethnicity on clinical outcomes in COVID-19: A systematic review. EClinicalMedicine. 2020;23:100404. DOI: https://doi.org/10.1016/j.eclinm.2020.100404
Supporting Agencies
NoneCopyright (c) 2022 Roberta Di Matteo, Tatiana Bolgeo, Denise Gatti, Menada Gardalini, Antonella Cassinari, Antonio Maconi
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Downloads
Citations
